ArticleAnnals of hematology2025

Allogeneic stem cell transplantation with prior pembrolizumab and bendamustine therapy induce complete metabolic response in relapsed/refractory classical hodgkin lymphoma with relapse after nivolumab.

Ugo Giordano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.